Topical Ruxolitinib for Cutaneous Chronic Graft Versus Host Disease (cGVHD)
Clinical trial NCT03395340 · TERMINATED
Trial details
- NCT number
- NCT03395340
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-19
- Primary completion
- 2019-01-31
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.